AQR Capital Management
ASMB icon

AQR Capital Management’s Assembly Biosciences ASMB Stock Holding History

AQR Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,870
Closed -$269K – 2221
2021
Q1 		$269K Sell
4,870
-3,339
-41% -$221K ﹤0.01% 2042
2020
Q4 		$596K Buy
8,209
+6,562
+398% +$770K ﹤0.01% 1724
2020
Q3 		$325K Sell
1,647
-9
-0.5% -$2.27K ﹤0.01% 1885
2020
Q2 		$463K Buy
1,656
+673
+68% +$157K ﹤0.01% 1769
2020
Q1 		$175K Buy
+983
New +$211K ﹤0.01% 1892
2018
Q4 		– Sell
-1,257
Closed -$560K – 2183
2018
Q3 		$560K Sell
1,257
-683
-35% -$320K ﹤0.01% 1917
2018
Q2 		$913K Sell
1,940
-1,913
-50% -$1.01M ﹤0.01% 1754
2018
Q1 		$2.27M Buy
3,853
+792
+26% +$491K ﹤0.01% 1299
2017
Q4 		$1.66M Buy
3,061
+1,899
+163% +$860K ﹤0.01% 1457
2017
Q3 		$487K Buy
+1,162
New +$356K ﹤0.01% 1945
2015
Q4 		– Sell
-1,644
Closed -$189K – 2241
2015
Q3 		$189K Buy
1,644
+747
+83% +$131K ﹤0.01% 2071
2015
Q2 		$207K Buy
+897
New +$173K ﹤0.01% 2102

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

AQR Capital Management's ASMB Position: Q2 2021 in Review

AQR Capital Management sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 4,870 shares — an estimated $269K sold.

AQR Capital Management first reported a position in ASMB in Q2 2015 and held it in 12 quarters. The position peaked at $2.27M in Q1 2018. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • AQR Capital Management reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • AQR Capital Management sold 4,870 Assembly Biosciences shares in Q2 2021, an estimated $269K.
  • AQR Capital Management first reported a position in Assembly Biosciences in Q2 2015 and held it in 12 quarters.
  • AQR Capital Management's Assembly Biosciences position peaked at $2.27M in Q1 2018.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.